Vitasora Health Limited (ASX:VHL)

Market Cap	28.09M -39.5%
Revenue (ttm)	4.84M +30.6%
Net Income	-10.61M
EPS	-0.01
Shares Out	2.34B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Open	0.0120
Previous Close	0.0120
Day's Range	0.0120 - 0.0120
52-Week Range	0.0090 - 0.0390
Beta	-0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About Vitasora Health

Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 30
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VHL

Financial Performance

In fiscal year 2026, Vitasora Health's revenue was 4.84 million, an increase of 30.63% compared to the previous year's 3.71 million. Losses were -10.61 million, -0.86% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 30, 2026

Data Sources Report a data error